The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there's a catch when it comes to bone health.

While caregiving can be meaningful and rewarding at manageable levels, those who spend more than 20 hours a week delivering unpaid care to others have poorer mental health outcomes, a McGill study has found.

The Belgium federation says it believes in "the principles of legal certainty, transparency, equal treatment and fair play."

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. In addition, 15 percent…

A new study, co-led by Mathias Schmidt from the Max Planck Institute of Psychiatry in Munich and Juan Pablo Lopez from Karolinska Institutet in Sweden, focused on the FKBP5 gene and its encoded protein, FKBP51, a well-established regulator of the body's stress hormone system that is heavily implicated in psychiatric vulnerability.

One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these are common symptoms, in older men they can significantly affect quality of life.

Fore Biotherapeutics secures $67M in one of year's largest biotech funding rounds - The Business Journals Fore Biotherapeutics secures $67M in one of year's largest biotech funding rounds The Business Journals

The Medicaid system incentivizes states and health insurance companies to enroll more patients, resulting in worse care and increased taxpayer costs, but market-based incentives could improve care and reduce costs.

New York City health officials are investigating a Legionnaires' disease cluster in two Upper East Side neighborhoods. As of July 6, there have been 23 cases, 17 hospitalizations and no deaths.

In 1981, a researcher at Mount Sinai School of Medicine named William Fitzgerald noticed something strange—his blood pressure was lower after going for a jog. This anecdotal observation launched a robust investigation into this phenomenon, which would later be identified as post-exercise hypotension (PEH). One of the leaders in this field is College of Agriculture, Health and Natural Resources (CAHNR) researcher and Board of Trustees Distinguished Professor of kinesiology Linda Pescatello.

Researchers from Fox Chase Cancer Center have identified a widely used thyroid hormone that may significantly improve treatment outcomes for medulloblastoma, the most common malignant brain tumor in children. The study found that adding triiodothyronine (T3), an FDA-approved hormone used to treat hypothyroidism, to standard chemotherapy could help prevent tumors from growing back after treatment. The findings were published in the journal Molecular Therapy Oncology.

State Awards Over $7M To Support Advanced Energy Sector Los Alamos Daily Post